{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "3935642", "DateCompleted": {"Year": "1986", "Month": "01", "Day": "29"}, "DateRevised": {"Year": "2017", "Month": "12", "Day": "13"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "8750-7587", "JournalIssue": {"Volume": "59", "Issue": "6", "PubDate": {"Year": "1985", "Month": "Dec"}}, "Title": "Journal of applied physiology (Bethesda, Md. : 1985)", "ISOAbbreviation": "J Appl Physiol (1985)"}, "ArticleTitle": "Significance of thromboxane generation in ozone-induced airway hyperresponsiveness in dogs.", "Pagination": {"StartPage": "1918", "EndPage": "1923", "MedlinePgn": "1918-23"}, "Abstract": {"AbstractText": ["To determine whether thromboxane A2 may be involved in ozone (O3)-induced airway hyperresponsiveness, we studied the effect of a thromboxane synthase inhibitor (OKY-046, 100 micrograms X kg-1 X min-1 iv) in five dogs exposed to O3. Airway responsiveness was assessed by determining the provocative concentration of acetylcholine aerosol that increased total pulmonary resistance by 5 cmH2O X l-1 X s. O3 (3 ppm) increased airway responsiveness as demonstrated by a decrease in acetylcholine provocative concentration from 2.42 (geometric SEM = 1.64) to 0.14 mg/ml (geometric SEM = 1.30). OKY-046 significantly inhibited this effect without altering pre-O3 responsiveness or the O3-induced increase in neutrophils and airway epithelial cells in bronchoalveolar lavage fluid. To further examine the role of thromboxane A2, we studied the effect of a thromboxane A2 mimetic, U-46619, on airway responsiveness in five additional dogs. U-46619 in subthreshold doses (i.e., insufficient to increase base-line pulmonary resistance) caused a fourfold increase in airway responsiveness to acetylcholine. Subthreshold doses of histamine had no effect. These results suggest that thromboxane A2 may be an important mediator of O3-induced airway hyperresponsiveness."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Aizawa", "ForeName": "H", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chung", "ForeName": "K F", "Initials": "KF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Leikauf", "ForeName": "G D", "Initials": "GD"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ueki", "ForeName": "I", "Initials": "I"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bethel", "ForeName": "R A", "Initials": "RA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "O'Byrne", "ForeName": "P M", "Initials": "PM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hirose", "ForeName": "T", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Nadel", "ForeName": "J A", "Initials": "JA"}], "GrantList": [{"GrantID": "HL-07185", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HL-24136", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Appl Physiol (1985)", "NlmUniqueID": "8502536", "ISSNLinking": "0161-7567"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Methacrylates"}, {"RegistryNumber": "0", "NameOfSubstance": "Prostaglandin Endoperoxides, Synthetic"}, {"RegistryNumber": "0", "NameOfSubstance": "Thromboxanes"}, {"RegistryNumber": "37H9VM9WZL", "NameOfSubstance": "Calcimycin"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "76898-47-0", "NameOfSubstance": "15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Prostaglandin-Endoperoxide Synthases"}, {"RegistryNumber": "L256JB984D", "NameOfSubstance": "ozagrel"}, {"RegistryNumber": "N9YNS0M02X", "NameOfSubstance": "Acetylcholine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Acetylcholine"}, {"QualifierName": ["drug effects"], "DescriptorName": "Airway Resistance"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Calcimycin"}, {"QualifierName": [], "DescriptorName": "Dogs"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Methacrylates"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Neutrophils"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Prostaglandin Endoperoxides, Synthetic"}, {"QualifierName": ["metabolism"], "DescriptorName": "Prostaglandin-Endoperoxide Synthases"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Respiratory System"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Thromboxanes"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1985", "Month": "12", "Day": "1"}, {"Year": "1985", "Month": "12", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1985", "Month": "12", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["3935642", "10.1152/jappl.1985.59.6.1918"]}}], "PubmedBookArticle": []}